ClinicalTrials.gg
Not yet recruitingNCT07942064RENEWUpdated Nov 17, 2026

Remote Exercise iNtErvention for Wellbeing (RENEW) Trial

A Phase 2 interventional study of Qualified exercise professional support and Exercise apps in Exercise Adherence (Primary), Depressive Symptoms (Secondary) and Anxiety (Secondary), sponsored by University of British Columbia. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by University of British Columbia · Phase 2, Interventional, and Prevention

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
664
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 34 studies in Depression by University of British Columbia — 9 open to participants now, 10 under way, 1 of them phase 3. Depression · University of British Columbia.

Planned enrollment
2nd of 34
664 · median 76
Started
2026
the only one that year
Phase 2
3 of 34
2 open now
Registered
34th of 34
by date

Among the 34 studies in Depression by University of British Columbia, this one is the 2nd largest by planned enrollment, is the only one that started in 2026, is one of 3 in phase 2, and was the 34th registered.

Depression

8,595 studies on the registry are indexed under Depression; 1,732 are open to participants now.

Browse Depression studies →

Open to participants now

9 of the 34 studies in Depression by University of British Columbia are open now, in 1 country. Recruiting first, the newest first:

3 more — sign in →

By country, each count listing its studies:

All 9 open studies →

Where they have run

Who these studies take

Of the 1,094 Depression studies recruiting now, 472 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 314 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 34 studies in Depression by University of British Columbia, or all of them as a file.
02

Study summary

Healthcare workers report significantly worse mental health and wellbeing than the average employed Canadian. Evidence suggests that healthcare workers' leisure-time physical activity is associated with higher mental and physical health, while occupational physical activity is not. Our pilot work demonstrated that previously inactive healthcare workers who develop sustained off-site, at-home exercise routines using mobile applications (apps) have improved depressive symptoms and burnout, and lower rates of sick leave. Yet, in our work, only 23% of healthcare workers remained engaged with the apps for at least 80 or more minutes on average per week at the end of the 12-week study. In semi-structured interviews completed following their participation in the study, healthcare workers voiced their desire to have support from our team to help them maintain their motivation and improve their adherence. Here, we propose to conduct a randomized trial with two conditions of an aerobic exercise mobile app (using a suite of apps for whole body weight-based training, yoga, pilates, and barre) with or without support from a qualified exercise professional trained in motivational interviewing to improve healthcare workers' engagement with the suite of apps in their leisure time. In turn, we aim to improve their mental health and wellbeing as their exercise levels increase. By targeting adherence, our goal is to develop a feasible, engaging, and accessible solution that can be implemented as a more widely utilized program in the future, for healthcare workers and beyond.

Read the detailed description

Healthcare workers (HCWs) represent the largest group of government employees in Canada. Regulated nurses, including registered nurses, nurse practitioners, licensed practical nurses, and registered psychiatric nurses, are the most prevalent, with registered nurses accounting for more than 93% of HCWs across the country. Shift work, high job strain, and low autonomy have each been associated with poorer physical and mental health among nurses. Likewise, physicians experience high levels of stress and face an elevated risk of burnout and illness. While previous research has shown improvements in health and wellbeing following an exercise intervention, less than one-quarter of healthcare workers fully engaged with the intervention by the end of the study.

Considering the above, the investigators propose a 2-arm parallel randomized efficacy trial, the Remote Exercise iNtErvention for Wellbeing (RENEW) trial, to support HCWs to convert intentions into maintenance. The present study will test whether supplementing free access to Down Dog™ applications (apps) with free support from a qualified exercise professional (QEP) trained in behaviour change techniques and motivational interviewing can lead to (1) improved adherence (i.e., increased moderate-to-vigorous physical activity; primary outcome) which, in turn, should lead to (2) improved mental health, wellbeing, and occupational functioning (secondary outcomes). Based on systematic reviews and meta-analyses demonstrating more sessions are more effective (with a minimum of 5 sessions), and with no standards yet to be recommended, we will provide 7 QEP-led sessions during the first 9 weeks, followed by 4 additional monthly boosters until the end of the trial. All participants will receive free access to Down Dog™'s suite of apps. Down Dog™ apps were selected for several reasons: i) variety of exercise options: body-weight interval training, yoga, barre, pilates; ii) diversity in difficulty levels (0-3), type (e.g., aerobic and/or resistance for interval training app), length of workout (4-60 min), interval bout (10-120 sec), and recovery time between bouts (0-60 sec); iii) no requirement for equipment; and iv) choice of music, language, and gender of the narrators and models in the videos.

03

Conditions studied

  • Exercise Adherence (Primary)
  • Depressive Symptoms (Secondary)
  • Anxiety (Secondary)
  • Presenteeism Secondary)
  • Wellbeing (Secondary)
  • Psychological Stress (Secondary)
  • Burnout (Secondary)
  • Absenteeism (Secondary)
  • Health Status Measures (Secondary)
  • Flourishing (Secondary)

Keywords

  • Behavior Change
  • Healthcare Workers
  • Intervention
  • Motivational Interviewing
  • Exercise Adherence
  • Mental Health
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals over the age of 18
  • Individuals who are employed/contracted by one of the 7 BC health authorities
  • Individuals who are capable of and cleared for moderate physical activity, as assessed by CSEP's Get Active Questionnaire or a physician or a CSEP-certified Clinical Exercise Physiologist

Exclusion criteria

Exclusion Criteria:

  • Prospective participants must be cleared to participate in exercise. The CSEP-Get Active Questionnaire will be used to minimize any risk of exercise and ensure the safety of individuals. If any to exercise are reported in the CSEP Get-Active Questionnaire, prospective participants will be required to obtain clearance from a physician or CSEP-Certified Clinical Exercise Physiologist prior to participation. If payment is required for this clearance, prospective participants will be reimbursed.
  • Individuals under the age of 18 will be excluded.
  • Individuals who are currently retired are ineligible to participate.
  • Individuals who are unable to speak and read English will be excluded for the following reasons: (a) some questionnaires used in the present study do not have validated translations \& (b) feasibility issues with the live translation of QEP sessions.
  • Individuals who currently engage in more than 60 minutes of structured exercise per week (assessed using the Stanford Leisure Time Activity Categorical Item) will be excluded.
  • Individuals who are currently pregnant will be excluded due to safety risks.
  • Individuals who plan to move outside of the province of British Columbia within the next 6 months (during which the trial will be taking place) will be excluded.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
664 participants (estimated)

Study arms

  • Experimental
    Apps + QEP

    * For the duration of the study, participants will be completing any of the physical activities customizable within the Down Dog™ applications (apps). Participants can also be supported to complete physical activity outside of the apps. They will be asked to complete a minimum of 90 mins/week of structured, planned exercise. * Participants will engage in 7 sessions led by qualified exercise professionals (QEPs) trained in Motivational Interviewing every week during the first 4 weeks and every 2 weeks for the following month. Starting at week 9, monthly booster sessions will be provided until end of month 6. Sessions will be held over Zoom™. * Participants will receive weekly and monthly surveys to complete. They will also complete a baseline prior to Week 1 and a final survey at the end of Week 24. * Participants will be shipped an ActiGraph Leap 2.0 device to wear once a month for 7 days, throughout their awake daily life for the measurement of physical activity outside of app use.

    Behavioral: Qualified exercise professional support · Behavioral: Exercise apps

  • Active comparator
    Apps Only

    * For the duration of the study, participants will be completing any of the physical activities customizable within the Down Dog™ applications (apps). They will be asked to complete a minimum of 90 mins/week. * Participants will receive weekly and monthly surveys to complete. They will also complete a baseline prior to Week 1 and a final survey at the end of Week 24. * Participants will be shipped an ActiGraph Leap 2.0 device to wear once a month for 7 days, throughout their awake daily life for the measurement of physical activity outside of app use.

    Behavioral: Exercise apps

Interventions

  • BehavioralQualified exercise professional support

    Participants randomized to the Apps + QEP group will meet with qualified exercise professionals (QEPs) trained in motivational interviewing. The first session will occur on Zoom™ within 1 week of randomization for a maximum 1-hour session to determine motivation and goals, and set workouts. These will be followed by maximum 30-minute sessions every week during the first four weeks (at the end of wks 1, 2, 3, 4) and every 2 weeks for weeks 5 through 8 (wks 6, 8) for a maximum of 30 minutes per session. Starting at week 12, monthly booster sessions (30 minutes max) will be provided until end of month 6. During sessions, QEPs will review progress and foster self-determined motivation. Drs. Ma and Puterman trained 10 QEPs (minimum Certified Person Trainer, Kinesiologist, or Clinical Exercise Physiologist) with a Bachelor's degree in Kinesiology including an advanced exercise prescription course. QEPs are provided with training in physical activity counselling and motivational interviewing.

  • BehavioralExercise apps

    All participants will receive free access to a suite of exercise applications (apps) from Down Dog™ for whole body weight-based training, yoga, pilates, and barre. Participants will be asked to exercise for a minimum of 90mins/week. Exercises can be completed at home or in any other preferred location, and with or without exercise equipment.

06

What researchers measure

Primary outcomes

  1. Exercise Engagement

    Leisure-time moderate-to-vigorous physical activity (MVPA) will be assessed using a combination of 7-day usage for the Down Dog™ applications (apps) and any additional MVPA with the research-grade ActiGraph LEAP 2.0 accelerometer at baseline for 7 days prior to randomization, and every 4 weeks up to 24 weeks (weeks 4, 8, 12, 16, 20, and 24).

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

Secondary outcomes

  1. Depressive Symptoms

    Assessed with the Center for Epidemiologic Studies Depression Scale-10-item (CESD-10). This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 30, with higher scores indicating more or more frequent symptoms.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  2. Anxiety Symptoms

    Assessed with the Generalized Anxiety Disorder-7 Scale (GAD-7). This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 21, with higher scores indicating more or more frequent symptoms.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  3. Perceived Stress

    Assessed with the Perceived Stress Scale 4-item (PSS-4). This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 16, with higher scores indicating more or more frequent symptoms.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  4. Psychological Flourishing

    Assessed with the Flourishing Scale. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 56, with higher scores indicating higher self-perceived success in important areas of functioning.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  5. Well-being

    Assessed with the WHO Well-Being Index. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 25, with higher scores indicating greater feelings of positive well-being.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  6. Resilience

    Assessed with the Brief Resilience Scale. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 30, with higher scores indicating greater self-perceived ability to recover from stressful events.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  7. Burnout

    Assessed with the 22-item Maslach Burnout Inventory-Human Services Survey (MBI-HSS) for HCWs. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Includes 5 items that measure cynicism (also referred to as depersonalization). Possible range in scores is 0 to 30, where higher scores indicates greater burnout. Includes 9 items that measure emotional exhaustion. Possible range in scores is 0 to 54, where higher scores indicates greater burnout. Includes 8 items that measure professional efficacy (previously referred to as personal accomplishment). Possible range in scores is 0 to 48, where higher scores indicates lower burnout.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  8. Absenteeism and Presenteeism

    Assessed with the WHO Health and Work Performance Questionnaire (HPQ) Short Form. This will be completed on a weekly basis up to 24 weeks, including at baseline. The absenteeism question (number of days reported missing work for health or vacation) will be asked weekly. Presenteeism will be asked monthly, and assesses past-month self-rated overall work performance. Possible range in scores for presenteeism is 0 to 30, with higher scores indicating more positive self-perceived job performance.

    Time frame: Tracked every week for 24 weeks (baseline, up to 24 weeks)

  9. Intention to Leave Profession

    Assessed with the 3-item Turnover Intentions Scale. This will be completed on a weekly basis up to 24 weeks, including at baseline. Possible range in scores is 3 to 18, with higher scores indicating greater intentions to leave one's current job.

    Time frame: Tracked every week for 24 weeks (baseline, up to 24 weeks)

  10. Determinants of Physical Activity

    Assessed with the 34-Item Determinants of Physical Activity Questionnaire. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 34 to 238, with higher scores indicating lower perceived barriers to engaging in physical activity across the contexts of physical activity knowledge, environmental factors, relationships and self-beliefs.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  11. Intervention Delivery

    Assessed with the 11-item Client Experience of Motivational Interviewing Questionnaire. This will be included in each monthly survey (weeks 4, 8, 12, 16, 20, and 24) for participants randomized into the Apps + QEP (qualified exercise professional) arm. Possible range in scores is 11 to 55, with higher scores indicating more positive experience receiving motivational interviewing intervention.

    Time frame: Tracked every 4 weeks up to 24 weeks

  12. Pain

    Assessed with the 5-item PROMIS Pain Questionnaire. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 4 to 30, with higher scores indicating greater experiences of symptoms and interference with important areas of functioning.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  13. Sleep Quality

    Assessed with the single-item Sleep Quality Scale. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). Possible range in scores is 0 to 10, with higher scores indicating better quality of sleep.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  14. Musculoskeletal Injury

    Assessed with the the Nordic Musculoskeletal Questionnaire, shortened and adapted to briefly assess the past month. This will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24). This survey uses a multiple choice response style.

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  15. Physical Health Symptoms

    Assessed with a survey instrument developed by the research team to track health symptoms. This survey uses a multiple choice response style and will be included in the baseline survey and each monthly survey (weeks 4, 8, 12, 16, 20, and 24).

    Time frame: Tracked every 4 weeks for 24 weeks (baseline, up to 24 weeks)

  16. Chronic Health Symptoms

    Assessed with a survey instrument developed by the research team to track identify chronic health symptoms. This survey uses a multiple choice response style and will be included in the baseline survey only.

    Time frame: Tracked at baseline

07

Study locations

1 site
  • Fitness, Aging, & Stress Laboratory
    Vancouver, British Columbia V6T 1Z1, Canada
08

References and documents

Publications

  • Dawson AP, Steele EJ, Hodges PW, Stewart S. Development and test-retest reliability of an extended version of the Nordic Musculoskeletal Questionnaire (NMQ-E): a screening instrument for musculoskeletal pain. J Pain. 2009 May;10(5):517-26. doi: 10.1016/j.jpain.2008.11.008. Epub 2009 Apr 2. PubMed 19345154 ↗
  • Snyder E, Cai B, DeMuro C, Morrison MF, Ball W. A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression. J Clin Sleep Med. 2018 Nov 15;14(11):1849-1857. doi: 10.5664/jcsm.7478. PubMed 30373688 ↗
  • Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS(R)-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018 Jul;27(7):1885-1891. doi: 10.1007/s11136-018-1842-3. Epub 2018 Mar 22. PubMed 29569016 ↗
  • Madson MB, Mohn RS, Schumacher JA, Landry AS. Measuring Client Experiences of Motivational Interviewing during a Lifestyle Intervention. Meas Eval Couns Dev. 2015 Apr 1;48(2):140-151. doi: 10.1177/0748175614544687. PubMed 25937700 ↗
  • Taylor N, Lawton R, Conner M. Development and initial validation of the determinants of physical activity questionnaire. Int J Behav Nutr Phys Act. 2013 Jun 11;10:74. doi: 10.1186/1479-5868-10-74. PubMed 23758912 ↗
  • Kessler RC, Barber C, Beck A, Berglund P, Cleary PD, McKenas D, Pronk N, Simon G, Stang P, Ustun TB, Wang P. The World Health Organization Health and Work Performance Questionnaire (HPQ). J Occup Environ Med. 2003 Feb;45(2):156-74. doi: 10.1097/01.jom.0000052967.43131.51. PubMed 12625231 ↗
  • Smith BW, Dalen J, Wiggins K, Tooley E, Christopher P, Bernard J. The brief resilience scale: assessing the ability to bounce back. Int J Behav Med. 2008;15(3):194-200. doi: 10.1080/10705500802222972. PubMed 18696313 ↗
  • Ingram PB 4th, Clarke E, Lichtenberg JW. Confirmatory Factor Analysis of the Perceived Stress Scale-4 in a Community Sample. Stress Health. 2016 Apr;32(2):173-6. doi: 10.1002/smi.2592. Epub 2014 Jul 4. PubMed 24995556 ↗
  • Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available. PubMed 6668417 ↗
  • Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092. PubMed 16717171 ↗
  • Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994 Mar-Apr;10(2):77-84. PubMed 8037935 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — All shared data will have all identification removed (i.e., de-identified data). All data used in analyses in a publication will be made available online.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Data will be shared following the publication of results.

Access criteria: Academic researchers conducting scientific analyses should submit a written request to the Principal Investigator.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Oct 2029, 35 months later.

Of 143 non-industry phase 2 interventional studies under Depression, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 57. This study's planned 35 months is close to that.

Counting every sponsor, half of 196 studies reached it within 31 months; a quarter within 18 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 17, 2026
StartEst.
Nov 10, 2026
Primary completionEst.
Oct 31, 2029
CompletionEst.
Oct 31, 2029
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07942064
Collaborators
Providence Health & Services, Canadian Institutes of Health Research (CIHR)
Responsible party
Eli Puterman (Professor, University of British Columbia) — Principal investigator
First posted
Nov 17, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Oct 31, 2029 (estimated)
Completion
Oct 31, 2029 (estimated)
Last update
Nov 17, 2026

Study contacts

Eli Puterman, PhD
Contact
eli.puterman@ubc.ca
604-822-2854
Portia Kuivi, BA
Contact
portia.kuivi@ubc.ca
604-827-2618
Eli Puterman, PhD
principal investigator · University of British Columbia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion